These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15682309)

  • 1. Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.
    Cho HS; D'Souza DC; Gueorguieva R; Perry EB; Madonick S; Karper LP; Abi-Dargham A; Belger A; Abi-Saab W; Lipschitz D; Bennet A; Seibyl JP; Krystal JH
    Psychopharmacology (Berl); 2005 Apr; 179(1):136-43. PubMed ID: 15682309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater vulnerability to the amnestic effects of ketamine in males.
    Morgan CJ; Perry EB; Cho HS; Krystal JH; D'Souza DC
    Psychopharmacology (Berl); 2006 Sep; 187(4):405-14. PubMed ID: 16896964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
    Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
    Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].
    Micallef J; Tardieu S; Gentile S; Fakra E; Jouve E; Sambuc R; Blin O
    Neurophysiol Clin; 2003 Jun; 33(3):138-47. PubMed ID: 12909392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
    Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
    Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle effects of ketamine on memory when administered following stimulus presentation.
    LaPorte DJ; Blaxton TA; Michaelidis T; Robertson DU; Weiler MA; Tamminga CA; Lahti AC
    Psychopharmacology (Berl); 2005 Jul; 180(3):385-90. PubMed ID: 15719220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a peripheral NMDA receptor antagonist on glutamate-evoked masseter muscle pain and mechanical sensitization in women.
    Castrillon EE; Cairns BE; Ernberg M; Wang K; Sessle BJ; Arendt-Nielsen L; Svensson P
    J Orofac Pain; 2007; 21(3):216-24. PubMed ID: 17717960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
    Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketamine in normal and schizophrenic volunteers.
    Lahti AC; Weiler MA; Tamara Michaelidis BA; Parwani A; Tamminga CA
    Neuropsychopharmacology; 2001 Oct; 25(4):455-67. PubMed ID: 11557159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects.
    van Berckel BN; Oranje B; van Ree JM; Verbaten MN; Kahn RS
    Psychopharmacology (Berl); 1998 Jun; 137(3):271-81. PubMed ID: 9683005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.
    Krystal JH; Petrakis IL; Limoncelli D; Webb E; Gueorgueva R; D'Souza DC; Boutros NN; Trevisan L; Charney DS
    Neuropsychopharmacology; 2003 Nov; 28(11):2020-8. PubMed ID: 12888778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
    Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
    Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects.
    Hallak JE; Dursun SM; Bosi DC; de Macedo LR; Machado-de-Sousa JP; Abrão J; Crippa JA; McGuire P; Krystal JH; Baker GB; Zuardi AW
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):198-202. PubMed ID: 21062637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
    Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
    Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade.
    Mickley GA; Kenmuir CL; McMullen CA; Snyder A; Yocom AM; Likins-Fowler D; Valentine EL; Weber B; Biada JM
    BMC Pharmacol; 2004 Oct; 4():28. PubMed ID: 15509306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.